Browse Category

Stock Market News 4 December 2025

Rocket Lab Stock (RKLB) Soars on Record Launch Cadence, $1.1 Billion Backlog and 2026 Neutron Bets – December 4, 2025 Update

Rocket Lab Stock (RKLB) Soars on Record Launch Cadence, $1.1 Billion Backlog and 2026 Neutron Bets – December 4, 2025 Update

Ticker: Rocket Lab Corporation (NASDAQ: RKLB) – Space launch and space systems Where Rocket Lab Stock Stands Today As of early afternoon on December 4, 2025, Rocket Lab shares trade around $48.80, up roughly 9% on the day and sitting firmly near the upper end of their recent range. The stock has a 52‑week range of $14.71 to $73.97 and…
Luminar Technologies (LAZR) Stock Jumps on Buyout Hopes Amid Volvo Split and Debt Crunch

Luminar Technologies (LAZR) Stock Jumps on Buyout Hopes Amid Volvo Split and Debt Crunch

As of December 4, 2025, Luminar Technologies, Inc. (NASDAQ: LAZR) is trading more like a distressed option on the future of lidar than a normal growth stock. The share price has bounced sharply intraday — up nearly 25% around midday Thursday to about $1.10–$1.14 — but that move comes after a brutal collapse from a 52‑week high of $10.40 and…
Lumentum (LITE) Stock Hits Record High on AI Datacenter Boom as Analysts Flag 20–40% Downside Risk – December 4, 2025

Lumentum (LITE) Stock Hits Record High on AI Datacenter Boom as Analysts Flag 20–40% Downside Risk – December 4, 2025

Lumentum Holdings Inc. (NASDAQ: LITE) has surged into the center of the AI infrastructure trade. As of December 4, 2025, the stock is trading around $325–$326 per share, near a fresh all‑time high, and has risen well over 200% in the last 12 months. StockAnalysis Yet behind the euphoria, a growing chorus of Wall Street and independent analysts warn that…
Circle Internet Group (CRCL) Stock on December 4, 2025: Volatile Rebound, Big Earnings Beat and Divided 2026 Forecasts

Circle Internet Group (CRCL) Stock on December 4, 2025: Volatile Rebound, Big Earnings Beat and Divided 2026 Forecasts

Circle Internet Group, Inc. (NYSE: CRCL) – the company behind the USDC and EURC stablecoins – is back in the spotlight after a violent few months that have turned it into one of 2025’s most hotly debated post‑IPO stocks. As of the close on December 4, 2025, Circle shares finished around the mid‑$80s (about $85.74), easing slightly after an 11%…
Kroger (KR) Stock Slides After Q3 2025 Earnings: Guidance, $2.6B Charge and Fresh Analyst Forecasts

Kroger (KR) Stock Slides After Q3 2025 Earnings: Guidance, $2.6B Charge and Fresh Analyst Forecasts

CINCINNATI — December 4, 2025 Kroger Co. (NYSE: KR) shares dropped roughly 4–5% on Thursday after the supermarket giant reported third‑quarter 2025 results that featured a sizable $2.6 billion impairment charge, a slight sales miss and a narrowed full‑year sales outlook — even as profits and margins came in strong and guidance for earnings per share was nudged higher. Kroger…
USA Rare Earth (USAR) Stock on December 4, 2025: New Supply Deal, Stillwater Magnet Plant, and Russell 2000 Inclusion – Is the Mine‑to‑Magnet Bet Worth It?

USA Rare Earth (USAR) Stock on December 4, 2025: New Supply Deal, Stillwater Magnet Plant, and Russell 2000 Inclusion – Is the Mine‑to‑Magnet Bet Worth It?

Snapshot: Where USA Rare Earth Stock Stands Today USA Rare Earth, Inc. (NASDAQ: USAR) has turned into one of the noisiest small caps in the critical minerals space in 2025 – part national‑security story, part SPAC saga, part good old‑fashioned speculative growth stock. As of mid‑day on December 4, 2025, USAR is trading in the mid‑$16s, up roughly 18% on…
Amgen (AMGN) Stock Near Record Highs on Obesity Drug Hopes – Is It Still a Buy in December 2025?

Amgen (AMGN) Stock Near Record Highs on Obesity Drug Hopes – Is It Still a Buy in December 2025?

Updated: December 4, 2025 Amgen Inc. (NASDAQ: AMGN) has quietly turned into one of 2025’s standout large‑cap healthcare winners. The biotech heavyweight is trading just below fresh 52‑week highs, powered by a clean sweep of earnings beats, a deepening obesity‑drug story around its MariTide program, and full FDA approval for its lung‑cancer therapy Imdelltra. At the same time, investors are…
BitMine Immersion Technologies (BMNR) Stock: $150M New ETH Buy, FY25 Earnings and 2026 Staking Pivot – Full Outlook as of December 4, 2025

BitMine Immersion Technologies (BMNR) Stock: $150M New ETH Buy, FY25 Earnings and 2026 Staking Pivot – Full Outlook as of December 4, 2025

BitMine Immersion Technologies, Inc. (NYSE American: BMNR) has become one of the most talked‑about crypto‑linked stocks on Wall Street. As of mid‑day on December 4, 2025, BMNR trades around $34–35 per share, giving the company a market capitalization of roughly $13.2 billion. StockAnalysis Behind that valuation sits a highly unusual balance sheet: BitMine now holds about 3.7 million Ether (ETH)…
Aurora Innovation (AUR) Stock Surges on Insider Buying and Driverless Milestones: Latest Price, News and 2026 Forecast (4 December 2025)

Aurora Innovation (AUR) Stock Surges on Insider Buying and Driverless Milestones: Latest Price, News and 2026 Forecast (4 December 2025)

Updated: December 4, 2025 Key takeaways AUR stock today: rally continues into December 4, 2025 As of mid‑day trading on December 4, 2025, Aurora Innovation, Inc. (NASDAQ: AUR) is changing hands around $4.64 per share, up roughly 2–3% on the session. Investing Over the last two weeks, the stock has staged a notable rebound. Technical analysts at StockInvest calculate that…
Check Point Software (CHKP) Stock Today: AI Firewall Launch, $1.75B Convertible Notes and Wall Street Forecasts

Check Point Software (CHKP) Stock Today: AI Firewall Launch, $1.75B Convertible Notes and Wall Street Forecasts

Date: December 4, 2025Ticker: Check Point Software Technologies Ltd. (NASDAQ: CHKP) Key Takeaways This article is for information and news purposes only and does not constitute financial advice or a recommendation to buy or sell any security. Where CHKP Stock Stands on December 4, 2025 As of late trading on December 4, 2025, Check Point Software shares are changing hands…
Oklo (OKLO) Stock Soars Over 13% on December 4, 2025 as Nuclear Hype Meets Wall Street Caution

Oklo (OKLO) Stock Soars Over 13% on December 4, 2025 as Nuclear Hype Meets Wall Street Caution

Published: December 4, 2025 Oklo stock today: a huge bounce in a very volatile name Oklo Inc. (NYSE: OKLO), the high‑profile advanced nuclear start‑up, is ripping higher again. As of mid‑day on December 4, 2025, Oklo shares trade around $109–110, up roughly 13–14% on the day, with an intraday range of about $94.6 to $109.7 and volume near 10 million…
IonQ, Inc. (IONQ) Stock Jumps on Quantum-AI and Defense Deals: December 4, 2025 Outlook

IonQ, Inc. (IONQ) Stock Jumps on Quantum-AI and Defense Deals: December 4, 2025 Outlook

IonQ’s stock is having another very “on‑brand” quantum day: volatile, loud, and hard to ignore. Around midday on December 4, 2025, IonQ, Inc. (NYSE: IONQ) was trading in the mid‑$50s, up double digits intraday after a string of headlines tying the company to biotech, defense drones, and big institutional money. StockAnalysis shows the shares around $54.20, up about 11%, in…

Stock Market Today

  • Merck Shares Appear Undervalued Despite Recent Price Gains, DCF Model Shows
    January 19, 2026, 3:44 AM EST. Merck's stock closed at $108.83 with a 7.7% return over 30 days and 15.3% over the past year, lagging peers. A discounted cash flow (DCF) model projecting future free cash flows estimates an intrinsic share value of $201.47, suggesting the stock is approximately 46% undervalued. Merck's recent share strength contrasts with market sentiment shaped by drug pipelines, regulation, and healthcare spending. The stock's price-to-earnings (P/E) ratio reflects investor expectations balancing growth and risk. Merck's five-year return stands at 64.8%, while its valuation metrics indicate potential long-term value despite moderate short-term gains.
Go toTop